G MED INNOVATIONS HLDGS LTD's ticker is GMVDW and the CUSIP is G39462117. A total of 6 filers reported holding G MED INNOVATIONS HLDGS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $140,000 | +55.6% | 1,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $90,000 | -82.0% | 1,000,000 | 0.0% | 0.00% | -80.0% |
| Q1 2022 | $500,000 | +66.7% | 1,000,000 | 0.0% | 0.01% | +100.0% |
| Q4 2021 | $300,000 | -23.9% | 1,000,000 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $394,000 | -61.9% | 1,000,000 | 0.0% | 0.01% | -63.2% |
| Q2 2021 | $1,035,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Psagot Value Holdings Ltd. / (Israel) | 159,838 | $63,000 | 0.01% |
| Psagot Value Holdings Ltd. | 159,838 | $63,000 | 0.01% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $394,000 | 0.01% |
| Warberg Asset Management LLC | 25,600 | $10,000 | 0.00% |
| UBS Group AG | 14,629 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |